NCT06998940 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT06998940
Title	Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	SWOG Cancer Research Network
Indications	pancreatic ductal adenocarcinoma
Therapies	Fluorouracil + Irinotecan + Leucovorin Gemcitabine + Nab-paclitaxel Gemcitabine + Nab-paclitaxel + Panitumumab Fluorouracil + Leucovorin + Liposomal irinotecan + Panitumumab Fluorouracil + Leucovorin + Liposomal irinotecan Fluorouracil + Irinotecan + Leucovorin + Panitumumab
Age Groups:	adult \| senior
Covered Countries	USA

Additional content available in CKB BOOST